Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 602Erstellt: 23. Oktober 2026

4-Pyridinemethanamine → 2-N-phenyl-4-N-(pyridin-4-ylmethyl)pyridine-2,4-diamine

https://huagongshe.com/de/reaction/602

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt4-PyridinemethanamineHCID 77317—
Edukt4-chloro-N-phenylpyridin-2-amineHCID 23458041—
ReagenzSodium t-butoxideHCID 23676156—
KatalysatorPalladium (II) acetateHCID 4144353—
Katalysator(R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine;Ferrocene, 1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, (2R)-HCID 144543273—
LösungsmittelDimethylacetamideHCID 31374—
Produkt2-N-phenyl-4-N-(pyridin-4-ylmethyl)pyridine-2,4-diamineHCID 10188369929,48%

Reaktionsbedingungen

Temperatur100 °C

Reaktionsschritte

Pyridin-4-ylmethanamine (58.1 mg, 0.54 mmol), 4-chloro-N-phenylpyridin-2-amine (100 mg, 0.49 mmol) and sodium 2-methylpropan-2-olate (94 mg, 0.98 mmol) were suspended in DMA (2 mL) and sealed into a microwave tube. Nitrogen was bubbled through the reaction mixture for 5 minutes. (R)-(-)-1-[(S)-2-(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE (32.5 mg, 0.06 mmol) and diacetoxypalladium (8.78 mg, 0.04 mmol) were added to the reaction mixture and nitrogen was bubbled through the reaction mixture for a further 5 minutes. The reaction was heated thermally to 100 °C for 30 mins under nitrogen and cooled to RT. The reaction mixture was neutralised with HCl and purified by ion exchange chromatography, using a 20 g SCX column. The crude product was purified by preparative HPLC (Waters SunFire column, 5µ silica, 50 mm diameter, 100 mm length), using decreasingly polar mixtures of water (containing 0.1% formic acid) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness N2-phenyl-N4-(pyridin-4-ylmethyl)pyridine-2,4-diamine (39.8 mg, 29.5 %) as an off white gum.

Herkunft & Nachweise

Quelldatensatz750 AstraZeneca ELN dataset
ORD IDord-42c0acd76af041bb93244dbfe53a7422
Quellennotiz750 AstraZeneca ELN dataset